RWM
PFE icon

RMG Wealth Management’s Pfizer PFE Stock Holding History

RMG Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.5K Buy
3,210
+170
+6% +$4.45K 0.01% 133
2026
Q1 		$78.5K Sell
3,040
-229
-7% -$6.1K 0.01% 137
2025
Q4 		$85.5K Hold
3,269
– – 0.01% 113
2025
Q3 		$81.2K Hold
3,269
– – 0.01% 105
2025
Q2 		$80K Buy
+3,269
New +$76.2K 0.01% 99

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RMG Wealth Management's PFE Position: Q2 2026 in Review

RMG Wealth Management increased its Pfizer (PFE) stake by 5.6% in Q2 2026, buying an estimated $4.45K and bringing the position to 3,210 shares worth $84.5K. The position accounts for 0.01% of the portfolio, ranked #133.

RMG Wealth Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $85.5K in Q4 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • RMG Wealth Management held 3,210 shares of Pfizer worth $84.5K as of Q2 2026.
  • RMG Wealth Management bought 170 Pfizer shares in Q2 2026, an estimated $4.45K.
  • Pfizer made up 0.01% of RMG Wealth Management's portfolio in Q2 2026, its #133 holding.
  • RMG Wealth Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • RMG Wealth Management's Pfizer position peaked at $85.5K in Q4 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.